Results · Apr-Jun 2026 · filed 4 Aug 2026
Dr. Agarwal's Health Care Q1 FY27 results
BlockbusterBlockbuster: sales up 20% or more & profit up 30% or more on the same quarter last year, with a wider operating margin.
Sales grew 26% to ₹614 crore from ₹487 crore in Apr-Jun 2025.
Operating profit grew 33% to ₹170 crore, an operating margin of 27.8% (up 1.5 points from a year ago).
Net profit grew 45% to ₹55 crore from ₹38.1 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales +9%, net profit +10%.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 614.0 | 487.4 | +26% |
| Operating profit (EBITDA) | 170.4 | 127.9 | +33% |
| Operating margin | 27.8% | 26.2% | +1.5 pts |
| Net profit | 55.0 | 38.1 | +45% |
Consolidated figures. Margins & ratios change in percentage points (pts).
The last 7 quarters
Filings that week
- 7 Aug 2026Announcement under Regulation 30 (LODR)-Earnings Call Transcript
- 4 Aug 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
- 4 Aug 2026Announcement under Regulation 30 (LODR)-Monitoring Agency Report
- 4 Aug 2026Announcement under Regulation 30 (LODR)-Investor Presentation
- 4 Aug 2026Consolidated And Standalone Unaudited Financial Results Of The Company For The Quarter Ended June 30, 2026.
- 4 Aug 2026Board Meeting Outcome for Consolidated And Standalone Unaudited Financial Results For The Quarter Ended June 30, 2026 And Disclosure Under Regulation 30 Of The
From the company's results filed on BSE (Consolidated). Business numbers only. Education & analysis, not investment advice or a recommendation.